Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
116TH CONGRESS
1ST SESSION
S. 2573
To amend the Controlled Substances Act to prohibit the knowing possession
of a pill press mold with intent to manufacture in violation of such
Act a counterfeit substance in schedule I or II in a capsule, tablet,
and other form intended for distribution, and for other purposes.
IN THE SENATE OF THE UNITED STATES
SEPTEMBER 26, 2019
Mr. CASSIDY (for himself and Ms. HASSAN) introduced the following bill;
which was read twice and referred to the Committee on the Judiciary
A BILL
To amend the Controlled Substances Act to prohibit the
knowing possession of a pill press mold with intent to
manufacture in violation of such Act a counterfeit sub-
stance in schedule I or II in a capsule, tablet, and
other form intended for distribution, and for other pur-
poses.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Criminalizing Abused
4
Substance Templates Act of 2019’’.
5
VerDate Sep 11 2014
21:32 Oct 09, 2019
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S2573.IS
S2573
jbell on DSK3GLQ082PROD with BILLS
2
•S 2573 IS
SEC. 2. UNLAWFUL POSSESSION OF PILL PRESS MOLDS.
1
(a) PROHIBITION.—Section 401 of the Controlled
2
Substances Act (21 U.S.C. 841) is amended by adding at
3
the end the following:
4
‘‘(i) OFFENSE REGARDING UNLAWFUL POSSESSION
5
OF PILL PRESS MOLDS.—
6
‘‘(1) IN
GENERAL.—Whoever, with intent to
7
manufacture in violation of this title a counterfeit
8
substance in schedule I or II in a capsule, tablet, or
9
other form for distribution, knowingly possesses a
10
pill press mold, shall be imprisoned not more than
11
20 years and fined in accordance with title 18,
12
United States Code.
13
‘‘(2) DEFINITIONS.—In this subsection, the
14
term ‘pill press mold’ means any punch, die, plate,
15
stone, or other object designed to print, imprint, or
16
reproduce on a controlled substance (or the con-
17
tainer or labeling thereof) the trademark, trade
18
name, or other identifying mark, imprint, number,
19
or device, or any likeness thereof, of a manufacturer,
20
distributor, or dispenser other than the person or
21
persons who in fact manufactured, created, distrib-
22
uted, or dispensed such product, thereby rendering
23
it a counterfeit substance.’’.
24
(b) SENTENCING GUIDELINES.—Pursuant to its au-
25
thority under section 994 of title 28, United States Code,
26
VerDate Sep 11 2014
21:32 Oct 09, 2019
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S2573.IS
S2573
jbell on DSK3GLQ082PROD with BILLS
3
•S 2573 IS
and in accordance with this section, the United States
1
Sentencing Commission shall review and amend, as appro-
2
priate, the Federal sentencing guidelines and policy state-
3
ments to ensure that the guidelines provide for a penalty
4
enhancement of not less than 2 offense levels above the
5
offense level otherwise applicable for a violation of section
6
401(a) of the Controlled Substances Act (21 U.S.C.
7
841(a)) if the defendant is found, in connection with such
8
violation of section 401(a), to be in violation of section
9
401(i) of the Controlled Substances Act, as added by sub-
10
section (a).
11
Æ
VerDate Sep 11 2014
21:32 Oct 09, 2019
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6301
E:\BILLS\S2573.IS
S2573
jbell on DSK3GLQ082PROD with BILLS